Table 1.
Patient demographics
| University of Pennsylvania N = 93 |
Stanford University N = 106 |
All Study Participants N = 199 |
|
|---|---|---|---|
| Age | |||
| Median (Range) | 52 (20 – 82) | 50 (17 – 87) | 51 (17 – 87) |
| Sex | |||
| Female | 79 (85%) | 78 (74%) | 157 (79%) |
| Male | 14 (15%) | 28 (26%) | 42 (21%) |
| Ethnicity | |||
| Caucasian | 82 (88%) | 74 (70%) | 156 (78%) |
| Hispanic | 5 (5%) | 12 (11%) | 17 (9%) |
| African American | 5 (5%) | 5 (5%) | 10 (5%) |
| Other | 1 (1%) | 15 (14%) | 16 (8%) |
| Disease Subtype | |||
| Classic | 47 (51%) | 83 (78%) | 130 (65%) |
| Skin-predominant1 | 46 (49%) | 23 (22%) | 69 (35%) |
| Study visits per patient | |||
| Median (Range) | 3 (1 – 12) | 2 (1 – 12) | 2 (1 – 12) |
| Baseline CDASI Activity Score | |||
| Median (Range) | 17 (0 – 47) | 21 (0 – 48) | 19 (0 – 48) |
| Baseline PGA VAS Score | |||
| Median (Range) | 1.1 (0 – 9.6) | 4.2 (0 – 9.7) | 3.2 (0 – 9.7) |
1
Skin-predominant subtype includes patients who had either amyopathic and hypomyopathic DM.